Fosfomycin disodium is under clinical development by Meitheal Pharmaceuticals and currently in Pre-Registration for Urinary Tract Infections.

21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), (the Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug ...

"Filling this gap in the market could allow patients with a simple but drug-resistant UTI to be treated at home, rather than be hospitalised for IV antibiotic therapy which puts them at risk of ...

Four tests that could allow people with urinary tract infections to receive the correct course of antibiotics more quickly are on course to be used by NHS hospitals, provided further research ...

Treatment for recurrent UTIs in a man might be a regular nightly low dose of an antibiotic. Specialists can prescribe a treatment called hippurate, an antiseptic that prevents infection by keeping ...

The analysis included 2,760 critically ill adults with suspected sepsis requiring critical care (41 units) within 24 hours of initiating intravenous antibiotics for suspected sepsis and likely to ...

Several factors influence the choice of antibiotics and the decision concerning if or when to switch from intravenous to oral antibiotics in the course of managing patients with community-acquired ...

Without a doubt there is a significant risk to patients who are on months of iv. antibiotics. Given the risks, it is impossible to argue that prolonged iv. antibiotics are ethically justified for ...

Omadacycline tosylate is under clinical development by Paratek Pharmaceuticals and currently in Phase I for Osteomyelitis.

Research shows that caffeine inhibits the action of some antibiotics, such as Avelox (moxifloxacin), Noroxin (norfloxacin), ...